Miriam O'Sullivan - 13 Feb 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

SEC form
4
Accepted by SEC
18 Feb 2025, 17:52:16 UTC
Prior SEC filing
14 Feb 2025
Next SEC filing
01 Dec 2025
Source filing
View source filing
Filing notes and source

Key filing fact

Miriam O'Sullivan filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 18 Feb 2025.

Key facts

  • This page summarizes Miriam O'Sullivan's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
  • 21 reported transactions and 9 derivative rows are listed below.
  • Accepted by SEC: 18 Feb 2025, 17:52.

Change

  • Previous filing in this sequence was filed on 14 Feb 2025.
  • Current net transaction value: -$108,126.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,123
Change %
+8.9%
Price
$0.000000
Shares after
13,702
Date
14 Feb 2025
Ownership
Direct
Footnotes
F1
BSX transaction

Common Stock

Tax liability

Transaction value
-$35,016
Shares
-330
Change %
-2.4%
Price
$106.11
Shares after
13,372
Date
14 Feb 2025
Ownership
Direct
BSX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+990
Change %
+7.4%
Price
$0.000000
Shares after
14,362
Date
16 Feb 2025
Ownership
Direct
Footnotes
F1
BSX transaction

Common Stock

Tax liability

Transaction value
-$30,878
Shares
-291
Change %
-2%
Price
$106.11
Shares after
14,071
Date
16 Feb 2025
Ownership
Direct
BSX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,000
Change %
+7.1%
Price
$0.000000
Shares after
15,071
Date
17 Feb 2025
Ownership
Direct
Footnotes
F1
BSX transaction

Common Stock

Tax liability

Transaction value
-$31,196
Shares
-294
Change %
-2%
Price
$106.11
Shares after
14,777
Date
17 Feb 2025
Ownership
Direct
BSX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+106
Change %
+6.9%
Price
$0.000000
Shares after
1,650
Date
14 Feb 2025
Ownership
By Spouse
Footnotes
F1
BSX transaction

Common Stock

Tax liability

Transaction value
-$4,032
Shares
-38
Change %
-2.3%
Price
$106.11
Shares after
1,612
Date
14 Feb 2025
Ownership
By Spouse
BSX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+85
Change %
+5.3%
Price
$0.000000
Shares after
1,697
Date
16 Feb 2025
Ownership
By Spouse
Footnotes
F1
BSX transaction

Common Stock

Tax liability

Transaction value
-$3,183
Shares
-30
Change %
-1.8%
Price
$106.11
Shares after
1,667
Date
16 Feb 2025
Ownership
By Spouse
BSX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+100
Change %
+6%
Price
$0.000000
Shares after
1,767
Date
17 Feb 2025
Ownership
By Spouse
Footnotes
F1
BSX transaction

Common Stock

Tax liability

Transaction value
-$3,820
Shares
-36
Change %
-2%
Price
$106.11
Shares after
1,731
Date
17 Feb 2025
Ownership
By Spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSX transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+2,355
Change %
Price
$0.000000
Shares after
2,355
Date
13 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,355
Exercise price
Footnotes
F1, F2
BSX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+6,061
Change %
Price
$0.000000
Shares after
6,061
Date
13 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,061
Exercise price
$106.14
Footnotes
F3
BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-1,123
Change %
-33%
Price
$0.000000
Shares after
2,248
Date
14 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,123
Exercise price
Footnotes
F1, F4
BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-990
Change %
-50%
Price
$0.000000
Shares after
990
Date
16 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
990
Exercise price
Footnotes
F1, F5
BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-1,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
17 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,000
Exercise price
Footnotes
F1, F6
BSX transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+188
Change %
Price
$0.000000
Shares after
188
Date
13 Feb 2025
Ownership
By Spouse
Underlying class
Common Stock
Underlying amount
188
Exercise price
Footnotes
F1, F2
BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-106
Change %
-33%
Price
$0.000000
Shares after
212
Date
14 Feb 2025
Ownership
By Spouse
Underlying class
Common Stock
Underlying amount
106
Exercise price
Footnotes
F1, F4
BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-85
Change %
-50%
Price
$0.000000
Shares after
85
Date
16 Feb 2025
Ownership
By Spouse
Underlying class
Common Stock
Underlying amount
85
Exercise price
Footnotes
F1, F5
BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-100
Change %
-100%
Price
$0.000000
Shares after
0
Date
17 Feb 2025
Ownership
By Spouse
Underlying class
Common Stock
Underlying amount
100
Exercise price
Footnotes
F1, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

Footnote F2

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.

Footnote F3

Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.

Footnote F4

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.

Footnote F5

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.

Footnote F6

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .